Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESNordson Corporation Names Joseph P. Kelley as Chief Financial Officer

Nordson Corporation Names Joseph P. Kelley as Chief Financial Officer

Nordson Corporation (today announced that Joseph P. Kelley has been named Executive Vice President and Chief Financial Officer, effective July 6, 2020. Mr. Kelley succeeds Gregory A. Thaxton, who previously announced his plans to retire. Upon Mr. Kelley’s start date, Mr. Thaxton will become Executive Vice President to the Company until he retires on August 28, 2020.

Mr. Kelley brings over 25 years of financial and operational expertise to the role. Since 2015, he has served as chief financial officer of Materion (NYSE: MTRN), a $1.2 billion advanced materials company. As CFO of Materion, Mr. Kelley partnered with business leaders to drive substantial increases in shareholder value, largely through commercial and operational improvement initiatives. He has a proven track record of driving financial results, which has earned him a successful career with roles of increasing responsibility at Materion, PolyOne (NYSE: POL) and Lincoln Electric (Nasdaq: LECO).

“As Nordson focuses on our next chapter of profitable growth, I am excited to welcome Joe to our executive leadership team. We are committed to advancing Nordson’s long-term strategic priorities of accelerating organic growth, diversifying through acquisition, leveraging the Nordson Business System and focusing on talent development. Joe’s operational experience, proven financial leadership and progressive viewpoint will make him an excellent business partner in achieving these goals,” said Sundaram Nagarajan, President and Chief Executive Officer of Nordson.

“As a Cleveland native, I’ve always admired Nordson, as a high-quality industrial precision technology company. Naga has a compelling vision for Nordson’s future, and I am excited to partner with him and the executive leadership team at this special time in the Company’s history,” said Mr. Kelley.

Added Mr. Nagarajan, “On behalf of the Board of Directors and Company, I want to thank Greg Thaxton for his commitment and leadership of Nordson over the past 30 years. He has been a great resource for me during my first nine months as CEO, and I know he will be an outstanding partner to Joe as well during this leadership transition period.”

Mr. Kelley started his career in progressive finance and auditing roles. In 2003, he joined Lincoln Electric, a $3.1 billion global manufacturer, where he was responsible for global consolidation and external reporting. Early in his tenure, he led the finance function for Lincoln Electric’s $600 million European region, where he was responsible for all accounting and finance activity across 12 legal entities in eight different countries. After four years in Europe, he returned to Lincoln Electric’s headquarters to lead investor relations and mergers and acquisitions.

In 2009, Mr. Kelley advanced his career as vice president of financial planning and investor relations at PolyOne Corporation, a $3.3 billion specialty chemical company. In this role, he was responsible for business segment financial planning and analysis, investor relations and long-range planning. In 2012, he joined Materion where he was ultimately promoted to chief financial officer, leading accounting, tax, treasury, financial planning, procurement and investor relations.

Mr. Kelley has a Bachelor of Science degree in business administration from John Carroll University.

Except for historical information and comparisons contained herein, statements included in this release may constitute “forward-looking statements,” as defined by the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors, as discussed in the Company’s filing with the Securities and Exchange Commission that could cause actual results to differ.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy